The Mechanism of Hsp90 Regulation by the Protein Kinase-Specific Cochaperone p50cdc37

Cell

Volumn 116, Issue 1, 2004, Pages 87-98

  Roe, S Mark ^a   Ali, Maruf M U ^a   Meyer, Philippe ^a,d   Vaughan, Cara K ^a   Panaretou, Barry ^b   Piper, Peter W ^c,e   Prodromou, Chrisostomos ^a   Pearl, Laurence H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ARGININE; CHAPERONE; DIMER; HEAT SHOCK PROTEIN 90; NUCLEOTIDE; PROTEIN KINASE; PROTEIN P50 CDC37; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; STRUCTURE ANALYSIS;

EID: 0742269688     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)01027-4     Document Type: Article

References (67)

1. An W.G., Schulte T.W., Neckers L.M. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. Cell Growth Differ. 11:2000;355-360.
2. Basso A.D., Solit D.B., Chiosis G., Giri B., Tsichlis P., Rosen N. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 277:2002;39858-39866.
3. Bijlmakers M.J., Marsh M. Hsp90 is essential for the synthesis and subsequent membrane association, but not the maintenance, of the Src-kinase p56(lck). Mol. Biol. Cell. 11:2000;1585-1595.
4. Blagosklonny M.V. Hsp-90-associated oncoproteins. multiple targets of geldanamycin and its analogs Leukemia. 16:2002;455-462.
5. Boudeau J., Deak M., Lawlor M.A., Morrice N.A., Alessi D.R. Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem. J. 370:2003;849-857.
6. Brugge J.S. Interaction of the Rous sarcoma virus protein pp60v-src with the cellular proteins pp50 and pp90. Curr. Top. Microbiol. Immunol. 123:1986;1-22.
7. CCP4 Collaborative Computational Project 4) The CCP4 suite. programs for protein crystallography Acta Crystallogr. D Biol. Crystallogr. 50:1994;760-763.
8. Chadli A., Bouhouche I., Sullivan W., Stensgard B., McMahon N., Catelli M.G., Toft D.O. Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90. Proc. Natl. Acad. Sci. USA. 97:2000;12524-12529.
9. Chavany C., Mimnaugh E., Miller P., Bitton R., Nguyen P., Trepel J., Whitesell L., Schnur R., Moyer J., Neckers L. p185erbB2 binds to GRP94 in vivo. Dissociation of the p. 185erbB2(GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2. J. Biol. Chem. 271):1996;4974-4977.
10. Dai K., Kobayashi R., Beach D. Physical interaction of mammalian CDC37 with CDK4. J. Biol. Chem. 271:1996;22030-22034.
11. DeLano W.L. The PyMOL Molecular Graphics System. 2002;DeLano Scientific, San Carlos, CA.
12. Dutta R., Inouye M. GHKL, an emergent ATPase/kinase superfamily. Trends Biochem. Sci. 25:2000;24-28.
13. Fontana J., Fulton D., Chen Y., Fairchild T.A., McCabe T.J., Fujita N., Tsuruo T., Sessa W.C. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ. Res. 90:2002;866-873.
14. Fujita N., Sato S., Ishida A., Tsuruo T. Involvement of Hsp90 in signaling and stability of 3- phosphoinositide-dependent kinase-1. J. Biol. Chem. 277:2002;10346-10353.
15. Grammatikakis N., Lin J.-H., Grammatikakis A., Tsichlis P.N., Cochran B.H. p50cdc37 acting in concert with Hsp90 is required for Raf-1 function. Mol. Cell. Biol. 19:1999;1661-1672.
16. Hunter T., Poon R.Y.C. Cdc37. A protein kinase chaperone? Trends Cell Biol. 7:1997;157-161.
17. Jones T.A., Zou J.-Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
18. Jones D.T., Taylor W.R., Thornton J.M. A new approach to protein fold recognition. Nature. 358:1992;86-89.
19. Lamzin V.S., Wilson K.S. Automated refinement for protein crystallography. Methods Enzymol. 277:1997;269-305.
20. Lange B.M.H., Rebollo E., Herold A., Gonzalez C. Cdc37 is essential for chromosome segregation and cytokinesis in higher eukaryotes. EMBO J. 21:2002;5364-5374.
21. Lee P., Rao J., Fliss A., Yang E., Garrett S., Caplan A.J. The Cdc37 protein kinase-binding domain is sufficient for protein kinase activity and cell viability. J. Cell Biol. 159:2002;1051-1059.
22. Leslie A.G.W. MOSFLM users guide. 1995;MRC Laboratory of Molecular Biology, Cambridge, UK.
23. Lotz G.P., Lin H., Harst A., Obermann W.M.J. Aha1 binds to the middle domain of Hsp90, contributes to client protein activation, and stimulates the ATPase activity of the molecular chaperone. J. Biol. Chem. 278:2003;17228-17235.
24. Mahony D., Parry D.A., Lees E. Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene. 16:1998;603-611.
25. Maloney A., Workman P. HSP90 as a new therapeutic target for cancer therapy. the story unfolds Expert Opin. Biol. Ther. 2:2002;3-24.
26. Meyer P., Prodromou C., Hu B., Vaughan C., Roe S.M., Panaretou B., Piper P.W., Pearl L.H. Structural and functional analysis of the middle segment of Hsp90. implications for ATP hydrolysis and client-protein and co-chaperone interactions Mol. Cell. 11:2003;647-658.
27. Miyata Y., Ikawa Y., Shibuya M., Nishida E. Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily. J. Biol. Chem. 276:2001;21841-21848.
28. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D. 53:1997;240-255.
29. Murzin A.G., Brenner S.E., Hubbard T., Chothia C. Scop. a structural classification of proteins database for the investigation of sequences and structures J. Mol. Biol. 247:1995;536-540.
30. Neckers L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol. Med. 8:2002;S55-S61.
31. Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K. Mechanism of dimer formation of the 90-kDa heat-shock protein. Eur. J. Biochem. 233:1995;1-8.
32. Obermann W.M.J., Sondermann H., Russo A.A., Pavletich N.P., Hartl F.U. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J. Cell Biol. 143:1998;901-910.
33. O'Keeffe B., Fong Y., Chen D., Zhou S., Zhou Q. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J. Biol. Chem. 275:2000;279-287.
34. Owens-Grillo J.K., Czar M.J., Hutchison K.A., Hoffmann K., Perdew G.H., Pratt W.B. A model of protein targeting mediated by immunophilins and other proteins that bind to hsp90 via tetratricopeptide repeat domains. J. Biol. Chem. 271:1996;13468-13475.
35. Panaretou B., Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J. 17:1998;4829-4836.
36. Panaretou B., Siligardi G., Meyer P., Maloney A., Sullivan J.K., Singh S., Millson S.H., Clarke P.A., Naaby-Hansen S., Stein R.et al. Activation of the ATPase activity of Hsp90 by the stress-regulated co-chaperone Aha1. Mol. Cell. 10:2002;1307-1318.
37. Pearl L.H., Prodromou C. Structure, function and mechanism of the Hsp90 molecular chaperone. Adv Protein Chem. 59:2002;157-185.
38. Pearl F.M.G., Lee D., Bray J.E., Sillitoe I., Todd A.E., Harrison A.P., Thornton J.M., Orengo C.A. Assigning genomic sequences to CATH. Nucleic Acids Res. 28:2000;277-282.
39. Perdew G.H., Wiegand H., VandenHeuvel J.P., Mitchell C., Singh S.S. A 50 kilodalton protein associated with raf and pp(60v-src) protein kinases is a mammalian homolog of the cell cycle control protein cdc37. Biochemistry. 36:1997;3600-3607.
40. Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell. Mol. Life Sci. 59:2002;1640-1648.
41. Pratt W.B., Toft D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. 228:2003;111-133.
42. Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell. 90:1997;65-75. a.
43. Prodromou C., Roe S.M., Piper P.W., Pearl L.H. A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone. Nat. Struct. Biol. 4:1997;477-482. b.
44. Prodromou C., Siligardi G., O'Brien R., Woolfson D.N., Regan L., Panaretou B., Ladbury J.E., Piper P.W., Pearl L.H. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J. 18:1999;754-762.
45. Prodromou C., Panaretou B., Chohan S., Siligardi G., O'Brien R., Ladbury J.E., Roe S.M., Piper P.W., Pearl L.H. The ATPase cycle of Hsp90 drives a molecular 'clamp' via transient dimerization of the N-terminal domains. EMBO J. 19:2000;4383-4392.
46. Richter K., Muschler P., Hainzl O., Buchner J. Coordinated ATP hydrolysis by the Hsp90 dimer. J. Biol. Chem. 276:2001;33689-33696.
47. Richter K., Reinstein J., Buchner J. N-terminal residues regulate the catalytic efficiency of the Hsp90 ATPase cycle. J. Biol. Chem. 277:2002;44905-44910.
48. Richter K., Muschler P., Hainzl O., Reinstein J., Buchner J. Sti1 is a non-competitive inhibitor of the Hsp90 ATPase. J. Biol. Chem. 278:2003;10328-10333.
49. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. The structural basis for inhibition of the Hsp90 molecular chaperone, by the anti-tumour antibiotics radicicol and geldanamycin. J. Med. Chem. 42:1999;260-266.
50. Sato S., Fujita N., Tsuruo T. Modulation of akt kinase activity by binding to hsp90. Proc. Natl. Acad. Sci. USA. 97:2000;10832-10837.
51. Scholz G.M., Cartledge K., Hall N.E. Identification and characterization of Harc, a novel Hsp90-associating relative of Cdc37. J. Biol. Chem. 276:2001;30971-30979.
52. Schulte T.W., Blagosklonny M.V., Ingui C., Neckers L. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J. Biol. Chem. 270:1995;24585-24588.
53. Shao J., Grammatikakis N., Scroggins B.T., Uma S., Huang W.J., Chen J.J., Hartson S.D., Matts R.L. Hsp90 regulates p50(cdc27) function during the biogenesis of the active conformation of the heme-regulated eIF2 alpha kinase. J. Biol. Chem. 276:2001;206-214.
54. cdc37. J. Biol. Chem. 277:2002;20151-20159.
55. Silverstein A.M., Grammatikakis N., Cochran B.H., Chinkers M., Pratt W.B. P50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J. Biol. Chem. 273:1998;20090-20095.
56. Soti C., Racz A., Csermely P. A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90-N-terminal nucleotide binding unmasks a C-terminal binding pocket. J. Biol. Chem. 277:2002;7066-7075.
57. Stancato L.F., Chow Y.-H., Hutchinson K.A., Perdew G.H., Jove R., Pratt W.B. Raf exists in a native heterocomplex with Hsp90 and p50 that can be reconstituted in a cell-free system. J. Biol. Chem. 268:1993;21711-21716.
58. Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U., Pavletich N.P. Crystal structure of an Hsp90-geldanamycin complex. targeting of a protein chaperone by an antitumor agent Cell. 89:1997;239-250.
59. Stepanova L., Leng X.H., Parker S.B., Harper J.W. Mammalian p50(Cdc37) is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 10:1996;1491-1502.
60. Tatebe H., Shiozaki K. Identification of Cdc37 as a novel regulator of the stress-responsive mitogen-activated protein kinase. Mol. Cell. Biol. 23:2003;5132-5142.
61. Vagin A., Teplyakov A. An approach to multi-copy search in molecular replacement. Acta Crystallogr. D Biol. Crystallogr. 56:2000;1622-1624.
62. Wegele H., Muschler P., Bunck M., Reinstein J., Buchner J. Dissection of the contribution of individual domains to the ATPase mechanism of Hsp90. J. Biol. Chem. 278:2003;39303-39310.
63. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., Neckers L.M. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins. essential role for stress proteins in oncogenic transformation Proc. Natl. Acad. Sci. USA. 91:1994;8324-8328.
64. Xu Y., Lindquist S. Heat-shock protein Hsp90 governs the activity of Pp60(V-Src) kinase. Proc. Natl. Acad. Sci. USA. 90:1993;7074-7078.
65. Xu Y., Singer M.A., Lindquist S. Maturation of the tyrosine kinase c-Src as a kinase and as a substrate depends on the molecular chaperone Hsp90. Proc. Natl. Acad. Sci. USA. 96:1999;109-114.
66. Xu W., Mimnaugh E., Rosser M.F., Nicchitta C., Marcu M., Yarden Y., Neckers L. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J. Biol. Chem. 276:2001;3702-3708.
67. Young J.C., Hartl F.U. Polypeptide release by Hsp90 involves ATP hydrolysis and is enhanced by the co-chaperone p23. EMBO J. 19:2000;5930-5940.